LDN Social Media
Get connected with us on social networks
The Use of LDN for Ophthalmic Conditions - Sebastian Denison, Pharm (2021 Conference) (LDN, low dose naltrexone)
This talk is about how they utilize LDN, their LDN protocol, and their outcomes and expectations. The information presented about humans can apply to animals as well.
He discusses some of the multiple mechanisms of LDN’s immune modulation. When looking at the ocular surface, the most key piece to fixing many problems is to control the inflammatory reaction and so, prevent damage. Inflammation is one of the most common signs of autoimmune disorders. He discusses the relationship of dry eye to many autoimmune disorders, and discusses various treatments, including low dose naltrexone (LDN) and its dosing.
KEYWORDS: immune, immune modulation, animal, immune modulation, dry eye, autoimmune, diabetes, mast cells, Sjogren’s, rheumatoid arthritis, scleroderma, systemic lupus, low dose naltrexone (LDN)
This is a summary of the presentation. Click on the video for full information.